Compounding pharmacies can resume making tirzepatide as FDA reconsiders scarcity
The Meals and Drug Management mentioned in a courtroom submitting overdue Friday that it will permit pharmacists to proceed making compounded variations of tirzepatide — the lively component in Eli Lilly’s diabetes